CPP Mediated Insulin Delivery: Current Status and Promising Future

ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)

Volume 16, 12 Issues, 2015

Download PDF Flyer

Current Pharmaceutical Biotechnology

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 152nd of 255 in Pharmacology & Pharmacy
  • 213th of 290 in Biochemistry & Molecular Biology

Submit Abstracts Online Submit Manuscripts Online

Zeno Foldes-Papp
Visiting Professor of Medical Biochemistry
HELIOS Clinical Center of Emergency Medicine
Department for Internal Medicine
Alte-Koelner-Strasse 9
D-51688 Koeln-Wipperfuerth

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.95
5 - Year: 2.558

CPP Mediated Insulin Delivery: Current Status and Promising Future

Current Pharmaceutical Biotechnology, 15(3): 240-255.

Author(s): Ergang Liu, Jianyong Sheng, Junxiao Ye, Yaping Wang, Junbo Gong, Victor C. Yang, Jianxin Wang and Huining He.

Affiliation: Department of Pharmaceutics, School of Pharmacy, Fudan University, 826 Zhangheng Rd, Shanghai 201203, P.R. China.


A variety of methods including penetrating enhancers, enzyme inhibitors, as well as cargo mediated drug delivery have been explored to improve the intolerance of parenteral administrated insulin, but little success has been achieved so far. Under this background, cell penetrating peptides (CPPs), with their ability to enhance transport efficiency of macromolecular drugs have been demonstrated to be able to increase insulin bioavailability (BA) in a number of studies, of which a BA up to 50.7% relative to subcutaneously administered insulin could be achieved by nasal route under optimal conditions. Furthermore, CPPs could be conveniently formulated with insulin, or be grafted onto drug-loaded cargoes to facilitate the cargo mediated insulin delivery. Here we reviewed the recent achievements on CPP-mediated insulin transport, and outlined various CPP-based delivery strategies which are expected to show potential in clinical translation in the future.


Bioavailability, cell-penetrating peptide, insulin, nonparenteral administration.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 15
Issue Number: 3
First Page: 240
Last Page: 255
Page Count: 16
DOI: 10.2174/1389201015666140813125840

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2015 Bentham Science